Eli Lilly And Co vs Wheaton Precious Metals Corp — how do they compare? Eli Lilly And Co trades at $1,223.11 (market cap $1.08T), while Wheaton Precious Metals Corp trades at $135.05 (market cap $60.94B). The key difference: Eli Lilly And Co is far larger — about 17.7× Wheaton Precious Metals Corp's market cap, and Wheaton Precious Metals Corp pays the higher dividend (0.58%). Which is the better fit depends on your goals.
| LLY | WPM | |
|---|---|---|
Market Cap | $1.08T | $60.94B |
Sector | Health | Basic Materials |
52-Week High | $1.24K | $165.72 |
52-Week Low | $639.43 | $91.02 |
Enterprise Value | $1.13T | $62.82B |
Dividend Yield | 0.57% | 0.58% |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,221.21, down 0.84% today, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength with bullish moving averages and support at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 48% revenue growth in Q2 2026. Recent news highlights the company's aggressive protection of its obesity drug pipeline against black market sales.
LLY presents a compelling growth story with dominant market positioning in weight-loss drugs and strong analyst support (73% buy ratings). Key risks include regulatory scrutiny and competitive pressures, but the company's raised guidance and pipeline advancements support continued upside toward the $1,380 consensus target.
Wheaton Precious Metals (WPM) trades at $135.51, up 1.59% on the day, reflecting strong momentum amid record financial performance. The stock exhibits a bullish technical trend, supported by consecutive earnings beats and robust cash flow growth. Recent results highlight significant revenue and profit expansion, driven by higher metal prices and increased sales volumes. Analyst sentiment remains overwhelmingly positive, with a consensus Buy rating and a price target implying substantial upside potential.
The outlook for WPM is favorable, underpinned by its high-margin streaming model and exposure to rising precious metal prices. Key opportunities include sustained earnings growth and strategic deal capacity, while risks involve commodity price volatility and execution of future streaming agreements. The stock's current valuation multiples suggest premium pricing, requiring continued operational excellence to justify further appreciation.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →